Cargando…
Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities?
Cancer remains a life-threatening disease and accounts for the major mortality rates worldwide. The practice of using biomarkers for early detection, staging, and customized therapy may increase cancer patients’ survival. Deubiquitinating enzymes (DUBs) are a family of proteases that remove ubiquiti...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society for Biochemistry and Molecular Biology
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476481/ https://www.ncbi.nlm.nih.gov/pubmed/30760385 http://dx.doi.org/10.5483/BMBRep.2019.52.3.048 |